Seres Therapeutics, Inc.

MCRBNASDAQUSD
7.30 USD
0.21 (2.87%)🟢PRE MARKET (AS OF 04:01 AM EDT)
🟢Market: OPEN
Open?$7.53
High?$7.53
Low?$7.53
Prev. Close?$7.32
Volume?2
Avg. Volume?49.9K
VWAP?$7.53
Rel. Volume?0.00x
Bid / Ask
Bid?$6.12 × 100
Ask?$8.82 × 100
Spread?$2.70
Midpoint?$7.47
Valuation & Ratios
Market Cap?70.2M
Shares Out?9.6M
Float?6.6M
Float %?72.7%
P/E Ratio?12.32
P/B Ratio?1.59
EPS?$0.59
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.56Strong
Quick Ratio?2.56Strong
Cash Ratio?2.37Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
12.3CHEAP
P/B?
1.59CHEAP
P/S?
88.94HIGH
P/FCF?
81.1PRICEY
EV/EBITDA?
-0.3CHEAP
EV/Sales?
30.93HIGH
Returns & Efficiency
ROE?
12.9%STRONG
ROA?
4.1%FAIR
Cash Flow & Enterprise
FCF?$865.0K
Enterprise Value?$24.4M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
77.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626